Mirum Pharmaceuticals, Inc. (MIRM)
100.66
+3.72
(+3.83%)
USD |
NASDAQ |
May 21, 16:00
100.66
0.00 (0.00%)
After-Hours: 19:59
Mirum Pharmaceuticals Research and Development Expense (TTM) : 237.68M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BridgeBio Pharma, Inc. | 467.16M |
| BioMarin Pharmaceutical, Inc. | 721.03M |
| Insmed, Inc. | 828.00M |
| Ionis Pharmaceuticals, Inc. | 923.53M |
| AnaptysBio, Inc. | 128.24M |